%PDF-1.4
%
41 0 obj
<>
endobj
38 0 obj
<>
endobj
99 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2003-11-11T16:48:29Z
2024-03-29T07:09:38-07:00
QuarkXPressª 4.11: AdobePS 8.8.0 (301)
2024-03-29T07:09:38-07:00
application/pdf
Heather
2003-203.dec
uuid:31f95ccf-1dd2-11b2-0a00-9008276d7200
uuid:31f95cd2-1dd2-11b2-0a00-b80000000000
endstream
endobj
27 0 obj
<>
endobj
28 0 obj
<>
endobj
42 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/Rotate 0/Thumb 15 0 R/Type/Page>>
endobj
1 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 17 0 R/Type/Page>>
endobj
4 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 19 0 R/Type/Page>>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 21 0 R/Type/Page>>
endobj
113 0 obj
[117 0 R]
endobj
114 0 obj
<>stream
1 g
/GS0 gs
0 792 m
0 792 l
f
q
-1 793 614 -794 re
W n
q
0 792.03 612 -792 re
W n
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
-0.00011 Tc 0.02499 Tw 8 0 0 8 57.6 714.5293 Tm
[(20.)-850.1 (Imashuku S, Hlbi S, )17.7 (T)69.9 (odo S. Hemophagocytic lymphohistiocytosis)]TJ
2.1 -1.25 Td
(in infancy and childhood. J Pediatr 1997;130:352-7.)Tj
-2.1 -1.25 Td
[(21.)-850.1 (Arico M, Janka G, Fischer )54.8 (A, et al. Hemophagocytic )]TJ
2.1 -1.25 Td
(lymphohistiocytosis. Report of 122 children from the International)Tj
0 -1.25 TD
[(Registry)64.9 (. FHL)-238.2 (Study Group of the Histiocyte Society)64.8 (. Leukemia)]TJ
0 Tc 0 Tw T*
(1996;10:197-203.)Tj
-0.00011 Tc 0.02499 Tw -2.1 -1.25 Td
[(22.)-850.1 (Sullivan KE, Delaat CA, Douglas SD, Filipovich )54.8 (AH. Defective)]TJ
2.1 -1.25 Td
(natural killer cell function in patients with hemophagocytic)Tj
T*
(lymphohistiocytosis and in first-degree relatives. Pediatr Res)Tj
0 Tc 0 Tw T*
(1998;44:465-8.)Tj
-0.00011 Tc 0.02499 Tw -2.1 -1.25 Td
[(23.)-850.1 (Arico M, )54.8 (Allen M, Brusa S, et al. Haemophagocytic )]TJ
2.1 -1.25 Td
(lymphohistiocytosis: proposal of a diagnostic algorithm based on)Tj
T*
[(perforin expression. Br J Haematol 2002;1)36.8 (19:180-8.)]TJ
-2.1 -1.25 Td
[(24.)-850.1 (Ravelli )54.8 (A, Magni-Manzoni S, Foti )17.7 (T)74 (, et al. Macrophage activation)]TJ
2.1 -1.25 Td
(syndrome in juvenile idiopathic arthritis: towards the development)Tj
T*
[(of diagnostic guidelines [abstract]. )54.8 (Arthritis Rheum 2001;44)]TJ
0 Tw T*
(Suppl:S166.)Tj
0.02499 Tw -2.1 -1.25 Td
[(25.)-850.1 (Emmenegger U, Reimers )54.8 (A, Frey U, et al. Reactive macrophage)]TJ
2.1 -1.25 Td
(activation syndrome: a simple screening strategy and its potential in)Tj
T*
[(early treatment initiation. Swiss Med )17.7 (Wkly 2002;132:230-6.)]TJ
-2.1 -1.25 Td
[(26.)-850.1 (Goransdotter Ericson K, Fadeel B, Nilsson-Ardnor S, et al.)]TJ
2.1 -1.25 Td
(Spectrum of perforin gene mutations in familial hemophagocytic)Tj
T*
[(lymphohistiocytosis. )54.8 (Am J Hum Genet 2001;68:590-7.)]TJ
-2.1 -1.25 Td
[(27.)-850.1 (Stepp SE, Dufourcq-Lagelouse R, Le Deist F)79.7 (, et al. Perforin gene)]TJ
2.1 -1.25 Td
(defects in familial hemophagocytic lymphohistiocytosis. Science)Tj
0 Tc 0 Tw T*
(1999;286:1957-9.)Tj
-0.00011 Tc 0.02499 Tw -2.1 -1.25 Td
[(28.)-850.1 (Dufourcq-Lagelouse R, Jabado N, Le Deist F)79.7 (, et al. Linkage of)]TJ
2.1 -1.25 Td
(familial hemophagocytic lymphohistiocytosis to 10q21-22 and)Tj
T*
[(evidence for heterogeneity)64.8 (. )54.8 (Am J Hum Genet 1999;64:172-9.)]TJ
30.9 35 Td
[(29.)-850.1 (Ohadi M, Lalloz MR, Sham P)110.7 (, et al. Localization of a gene for)]TJ
2.1 -1.25 Td
(familial hemophagocytic lymphohistiocytosis at chromosome)Tj
0 Tc T*
[(9q21.3-22 by homozygosity mapping. )54.8 (Am J Hum Genet)]TJ
0 Tw T*
(1999;64:165-71.)Tj
-0.00011 Tc 0.02499 Tw -2.1 -1.25 Td
[(30.)-850.1 (Normand N, Lehman )17.7 (TJA, Elkon KB, Onel KB. Lower expression)]TJ
2.1 -1.25 Td
[(of perforin in CD8+ )17.7 (T)-257.1 (cells of patients with systemic onset juvenile)]TJ
T*
[(rheumatoid arthritis [abstract]. )54.8 (Arthritis Rheum 2000;43)]TJ
0 Tw T*
(Suppl:S406.)Tj
0.02499 Tw -2.1 -1.25 Td
[(31.)-850.1 (W)39.8 (ulf)17.7 (fraat N, Brinkman D, Prieur )54.8 (AM, ten Cate RC, van der Net JJ,)]TJ
2.1 -1.25 Td
[(Kamphuis SSM. )54.8 (Autologous stem cell transplantation for refractory)]TJ
T*
[(juvenile idiopathic arthritis [abstract]. )54.8 (Arthritis Rheum 2000;43)]TJ
0 Tw T*
(Suppl:S381.)Tj
0.02499 Tw -2.1 -1.25 Td
[(32.)-850.1 (Grom )54.8 (AA, Lee S, )17.7 (V)59.8 (illanueve J, Passo M, Filipovich )54.8 (A. Natural)]TJ
2.1 -1.25 Td
(killer cell dysfunction with macrophage activation syndrome in)Tj
T*
[(systemic onset juvenile rheumatoid arthritis [abstract]. )54.8 (Arthritis)]TJ
0 Tc T*
(Rheum 2002;46 Suppl:S472.)Tj
-0.00011 Tc -2.1 -1.25 Td
[(33.)-850.1 (Henter JI, Samuelsson-Horne )54.8 (A, )54.8 (Arico M, et al. )17.7 (T)35 (reatment of)]TJ
2.1 -1.25 Td
(hemophagocytic lymphohistiocytosis with HLH-94)Tj
T*
(immunochemotherapy and bone marrow transplantation. Blood)Tj
0 Tc 0 Tw T*
(2002;100:2367-73.)Tj
-0.00011 Tc 0.02499 Tw -2.1 -1.25 Td
[(34.)-850.1 (Henter JI, )54.8 (Arico M, Egeler RM, et al. HLH-94: a treatment protocol)]TJ
2.1 -1.25 Td
(for hemophagocytic lymphohistiocytosis. HLH Study Group of the)Tj
T*
[(Histiocyte Society)64.8 (. Med Pediatr Oncol 1997;28:342-7.)]TJ
-2.1 -1.25 Td
[(35.)-850.1 (Ravelli )54.8 (A, De Benedetti F)79.7 (,)-0.1 ( )17.7 (V)59.8 (iola S, Martini )54.8 (A. Macrophage )]TJ
2.1 -1.25 Td
(activation syndrome in systemic juvenile rheumatoid arthritis)Tj
T*
(successfully treated with cyclosporine. J Pediatr 1996;128:275-8.)Tj
ET
0 0 0 1 K
54 54 m
558 54 l
S
BT
/T1_1 1 Tf
8 0 0 8 420.3613 35.9844 Tm
(The Journal of Rheumatology 2003; 30:12)Tj
0 Tc 0 Tw -45.7952 -0.0313 Td
(2516)Tj
ET
0 0 0 0 k
/GS0 gs
109.25 59.1 396.47 -10.84 re
f*
0.5 w
109.25 59.1 396.47 -10.84 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 0 0 rg
/GS2 gs
/T1_2 8 Tf
117.48 51 Td
(Personal, non-commercial use only. The Journal of Rheumatology Copyrig\
ht \251 2003. All rights reserved.)Tj
ET
Q
BT
0 g
/GS2 gs
/T1_3 1 Tf
10 0 0 10 540 17 Tm
( )Tj
0 0.48627 0.77255 rg
/GS2 gs
-7.22298 0 Td
(www.jrheum.org)Tj
0 g
/GS2 gs
-16.72996 0 Td
(Downloaded on March 29, 2024 from )Tj
ET
endstream
endobj
21 0 obj
<>stream
8;Z\5Mf-He#ikr7OPe`n$-&d:Bsl-]S+'EXY=X!V6W=GIO+N2OEAbC8B`J,2e2B:n
h2YiL+76lkIDsCcZJ\T#4$nLS,.+l!XS5r.Rmi%8/J0l7UTNF,OCtculK\">rH[t3;L5;GN2`*!D>E9"9\c?r:_:1MaD!#lJtA=6gm:_iD1`QG&,-;$7&5ta
8%H2Fb\,LA7/SA0U!-t;P1MqX*Z9Z/iJUH_ZTi#-+fI@M]TT9o9>%fk$_Ns^g/Mmo
8;CI&))q(\Y2E7TIXm,:#ruL-AqSh(OKbgOgt?Y>>dOgb/7s'9Vahp*@$ZdJ;pD>L
*gRaQC-E)RMh<+65(aESmh@F5qrUf6siRDj),Wc2kF=PXC)
^qpELf**#aQY3jl%lY+M0U_YpL;:kIg$Kc]c\A1_BD4l+6ti=!6D74('FKO\Thm.b
0]Y7N@Urp;?.hBq/Oq;2_qqp&2807p+P*cc~>
endstream
endobj
25 0 obj
[/Indexed/DeviceRGB 255 24 0 R]
endobj
24 0 obj
<>stream
J,g]g+e/h_!_gCtO=0f)$P%cIi8Zdfc5&3j_8$7g.@L`YKUJNGBP\poR=_;Dl'P(T
(7Boo^^S:71(MN]ZQX/+Cbu.lK"p74pe1T%s.DY%&\1TdJhr54.M9au6>79n6`Q:4
PbLSZTLEE(8E@'*1mg_*eTnN*;*'V3+gm-EEetX%;Bo$ur2ss*N`.-!.kG_q6GDD'
dKoL!8Ka#EV,@V!\j8ZFbp6EE<9cn=N6j0nf;(&;QU6bUD')c@\
9-d\DA=cZ0Q>gIM$$;cd2O@&a;X,Nn_aP(]I1aRc(K1^ue>
gF/(+GaKo$qneLWDrQ#;5\S(\$q'4Q,85`-8;S(=Z"WSBOV*FM)4,?B],R
endstream
endobj
46 0 obj
<>
endobj
47 0 obj
<>
endobj
90 0 obj
<>
endobj
104 0 obj
<>
endobj
44 0 obj
<>
endobj
72 0 obj
<>stream
HUyTSg^Q <-.RE+`)eMdaM@!!ȢRFZuZŏ93̙999|lm0ǝn
X#D(nG1okY7ٰ394ۙ#m<9mYT_k_s&Z{.tNjgL1ǩ
ScbO//uDT/g|,^o첷v+0[2@,c6$Hi\0>"6WH24}ʘ(F.{.&P +?H"e<"Z&FIٿrev?1ܺI6Hpl6`q<1ǖp'bOj,cg6669][/[-"bd#w)BR4v'xLi>˘LNrʒ)?::8:r*uzV(%C'N&Rh>DQŒ=U)sڒL-x9&Ǫ}9
>8bEІ-!.m\w탛7.V
(Ğ;F9o=[s`]U(BiY^YsP@pOT Ty6܃lٱmD~S?|p;LT'(x`~#2{']VQXUh!l{تwu⏲.Fuhఎoz-SVUaC \"T/2)'rs1" ͦO #<PQcbtiʂ+]%ͫR' Av܍(iguj+߭4KjR5\ܗfv^MSx^`\Pu @Cc#f08ZJns_nED2Dl]!|Xz/{~f!l+?XR>,CKKf]{U荝Fm˔Qk ·;t|](a$AC(4I74!}}*d"b\L:+;di<kдD#ehn#i;F 9_!0ot3:%ft.%fr
L٦U ;Z6;s];YvMErT2:>S뽎Rh'yW3̍K ^ޠ(48lz_p@e-V(p_2r"CPA@-mM(=Q4Z`Բ+
MvQJDJk\vjsX}scNRYkjSOC$l?]L^'$;'ԕq0p[r7hUdZjH}V C! +$@g
ԺTe]
cֺ];{ֱY;|;眗J$KdGۜ?aN$Rզ6rdMEW?o[\tV7۷>#|Bs3x|ю!];Ϧ 6>BO)*]qbmI/VG/Fcb7mU.4=>/4d'=3r-VI˓f֕#hFEB&.P/ezu=AD,y[ s]t
n: (fͅQ'knEox)@'{U@Gb1:w0
s~\riiiy=b&Q)*ٶyMҦPX1CJ,
[7[4X e#{QiI]h,ik_--;v
96LޢTYeۜT:Ii( =.w4$=u 3ui^[6fD#qWЬ6̸։$ތ0fLO+s'#b
uإ}0 lN&c+̟F==-F80,V#:?\\>b3\jTKECh9n tibvz4F
@a
Z]hځ>Y3b)ﲤj|^styz[XkX,͓JrbAk$[q:V\*+;Qa%{Z:-%ι,ٿ̭:QQ2R"NB
Y\{(3
5'3}irۛ{ITzj7ewmbi )
$EA^;$Kfpj57w4+zDU4FϬ'Au
g$'H7j5
4Rmn1}'Nr:GY`(TXqtqR(CH.Ӷry;+-FEyB$±
ejv4 "$Uf[rK5 !|NZT_t@{TztNݺ*^m22D 36'Ëzgb ar8E/
_ab8x)јuVut٠bUTo+4$Oj)y"}f hK:UVQ<2T"D{kPi6eeYyy>I舛pl (Gc քh5@SkTZ'^0fsb0'bQYL=WS$j#?zaGܡ!l2)2!QVd"[UG*"LZU'`Q~_ay0>ώ"[
]FOzҤPߌ0ab;^!NZ0EZ&_i_EAmXMLud_"?5wSǺw1&vI+byx8oyF^cĮrҟaI5]ޫyZkt!=3;GB>x>LSI5gC2G;'Pi{T \L2ng}t Be'=QPt]%TGXn\= ߫G>_efخFNU6'%ڮ>N*N99Jvv.lm
݈ZrJP[$NaSEG)`ЙrEWE<LCّ,H]bl'wljl6,0*)yԼ-DmXyx
#s^$Wp2dO T[2-U"*:U>"Mɽ/LmzՆ'*n{8
(e %i7`, +IG:3sA+P ޒn+Ű1.;ý>43.p͕t#\qHTqTadk*f0*(Z/-t9u6/SώsN\mMRMePi雂nD;v<|yWݬR|&3;TL䍽CaTd]"v.PdQM}̩l&Q|nMeӱR'b7@wOa<ޜ>.6L=$qIQI<Ńh>J6
g.8VKm.O_CD0,Vn|\/m@`ccppvm1
Y6R99G } vVՠ)fe7=fMGd/㲋'{` I
ם`4I Zw\
jE[&3L[Z҇`%<[eˎɫ'oZMҪF-
k_1Fzv锼?92='*3ثB;{gE40ĦwMZI$P+Z@Q[xtNF 3kv
[F~2MWBd^v.e8iHoob~uFútmG^
bQߒÕwXqW,$՚S21N;$o\"j78S'X5^h$EmM@Ta]f0]a1 Q9*х<[UqJ+PW\0}=pcTFIm0a:X86YʽtyFVM5<ֆ5Έ]%۠@KςF;]2A~&